Diagnosis, monitoring, and management of axial spondyloarthritis.
Ankylosing spondylitis
Axial spondyloarthritis
Diagnosis
Disease management
Spondylarthritis
Telehealth
Treatment
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
17 May 2024
17 May 2024
Historique:
received:
27
03
2024
accepted:
02
05
2024
medline:
17
5
2024
pubmed:
17
5
2024
entrez:
17
5
2024
Statut:
aheadofprint
Résumé
Axial spondyloarthritis (axSpA) is a chronic condition predominantly affecting the spine and sacroiliac joints. This article provides an in-depth overview of the current approaches to diagnosing, monitoring, and managing axSpA, including insights into developing terminology and diagnostic difficulties. A substantial portion of the debate focuses on the challenging diagnostic procedure, noting the difficulty of detecting axSpA early, particularly before the appearance of radiologic structural changes. Despite normal laboratory parameters, more than half of axSpA patients experience symptoms. X-ray and magnetic resonance imaging (MRI) are essential for evaluating structural damage and inflammation. MRI can be beneficial when there is no visible structural damage on X-ray as it can help unravel bone marrow edema (BME) as a sign of ongoing inflammation. The management covers both non-pharmacological and pharmacological approaches. Lifestyle modifications, physical activity, and patient education are essential components of the management. Pharmacological therapy, including nonsteroidal anti-inflammatory drugs (NSAIDs) and biologic disease-modifying anti-rheumatic drugs (bDMARDs), are explored, emphasizing individualized treatment. To effectively manage axSpA, a comprehensive and well-coordinated approach is necessary, emphasizing the significance of a multidisciplinary team. Telehealth applications play a growing role in axSpA management, notably in reducing diagnostic delays and facilitating remote monitoring. In conclusion, this article underlines diagnostic complexities and emphasizes the changing strategy of axSpA treatment. The nuanced understanding offered here is designed to guide clinicians, researchers, and healthcare providers toward a more comprehensive approach to axSpA diagnosis and care.
Identifiants
pubmed: 38758383
doi: 10.1007/s00296-024-05615-3
pii: 10.1007/s00296-024-05615-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Narodowe Centrum Badań i Rozwoju
ID : 0026/2019-00
Informations de copyright
© 2024. The Author(s).
Références
Navarro-Compán V, Sepriano A, El-Zorkany B, van der Heijde D (2021) Axial spondyloarthritis. Ann Rheum Dis 80:1511–1521. https://doi.org/10.1136/annrheumdis-2021-221035
doi: 10.1136/annrheumdis-2021-221035
pubmed: 34615639
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368. https://doi.org/10.1002/art.1780270401
doi: 10.1002/art.1780270401
pubmed: 6231933
Kucybała I, Urbanik A, Wojciechowski W (2018) Radiologic approach to axial spondyloarthritis: where are we now and where are we heading? Rheumatol Int 38:1753–1762. https://doi.org/10.1007/s00296-018-4130-1
doi: 10.1007/s00296-018-4130-1
pubmed: 30132215
pmcid: 6132717
Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000–1008. https://doi.org/10.1002/art.20990
doi: 10.1002/art.20990
pubmed: 15818678
Khan MA, van der Linden S (2019) Axial Spondyloarthritis: A Better Name for an Old Disease: A Step Toward Uniform Reporting. ACR Open Rheumatol 1:336–339. https://doi.org/10.1002/acr2.11044
doi: 10.1002/acr2.11044
pubmed: 31777810
pmcid: 6857996
Rudwaleit M, Landewé R, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776. https://doi.org/10.1136/ard.2009.108217
doi: 10.1136/ard.2009.108217
pubmed: 19297345
Citera G, Bautista-Molano W, Peláez-Ballestas I, Azevedo VF, Perich RA, Méndez-Rodríguez JA, Cutri MS, Borlenghi CE (2021) Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis. Adv Rheumatol 61:2. https://doi.org/10.1186/s42358-020-00161-5
doi: 10.1186/s42358-020-00161-5
pubmed: 33419481
Costantino F, Talpin A, Said-Nahal R, Goldberg M, Henny J, Chiocchia G, Garchon HJ, Zins M, Breban M (2015) Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis 74:689–693. https://doi.org/10.1136/annrheumdis-2013-204436
doi: 10.1136/annrheumdis-2013-204436
pubmed: 24351517
Tłustochowicz M, Brzozowska M, Wierzba W, Raciborski F, Kwiatkowska B, Tłustochowicz W, Jacyna A, Marczak M, Kisiel B, Śliwczyński A (2020) Prevalence of axial spondyloarthritis in Poland. Rheumatol Int 40:323–330. https://doi.org/10.1007/s00296-019-04482-7
doi: 10.1007/s00296-019-04482-7
pubmed: 31802208
López-Medina C, Moltó A (2018) Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis. Best Pract Res Clin Rheumatol 32:241–253. https://doi.org/10.1016/j.berh.2018.10.006
doi: 10.1016/j.berh.2018.10.006
pubmed: 30527429
Boel A, van Lunteren M, López-Medina C, Sieper J, van der Heijde D, van Gaalen FA (2022) Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study. RMD Open 8:e002174. https://doi.org/10.1136/rmdopen-2021-002174
doi: 10.1136/rmdopen-2021-002174
pubmed: 35301267
pmcid: 8932257
Dougados M, Etcheto A, Molto A et al (2015) Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort. Joint Bone Spine 82:345–351. https://doi.org/10.1016/j.jbspin.2015.02.006
doi: 10.1016/j.jbspin.2015.02.006
pubmed: 26190454
Sieper J, van der Heijde D (2013) Review: Nonradiographic axial spondyloarthritis: new definition of an old disease? Arthritis Rheum 65:543–551. https://doi.org/10.1002/art.37803
doi: 10.1002/art.37803
pubmed: 23233285
van Gaalen FA, Rudwaleit M (2023) Challenges in the diagnosis of axial spondyloarthritis. Best Pract Res Clin Rheumatol 37:101871. https://doi.org/10.1016/j.berh.2023.101871
doi: 10.1016/j.berh.2023.101871
pubmed: 37714776
Poddubnyy D (2020) Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology. https://doi.org/10.1093/rheumatology/keaa250
doi: 10.1093/rheumatology/keaa250
pubmed: 33053191
pmcid: 7566535
Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63:535–543. https://doi.org/10.1136/ard.2003.011247
doi: 10.1136/ard.2003.011247
pubmed: 15082484
pmcid: 1754994
Adshead R, Donnelly S, Knight P, Tahir H (2020) Axial Spondyloarthritis: Overcoming the Barriers to Early Diagnosis-an Early Inflammatory Back Pain Service. Curr Rheumatol Rep 22:59. https://doi.org/10.1007/s11926-020-00923-6
doi: 10.1007/s11926-020-00923-6
pubmed: 32808099
Rudwaleit M, Feldtkeller E, Sieper J (2006) Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis 65:1251–1252. https://doi.org/10.1136/ard.2005.051045
doi: 10.1136/ard.2005.051045
pubmed: 16905586
pmcid: 1798277
Lorenzin M, Ometto F, Ortolan A, Felicetti M, Favero M, Doria A, Ramonda R (2020) An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision. Ther Adv Musculoskelet Dis. https://doi.org/10.1177/1759720X20934277
doi: 10.1177/1759720X20934277
pubmed: 32636944
pmcid: 7315656
van den Berg R, de Hooge M, van Gaalen F, Reijnierse M, Huizinga T, van der Heijde D (2013) Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 52:1492–1499. https://doi.org/10.1093/rheumatology/ket164
doi: 10.1093/rheumatology/ket164
pubmed: 23650623
Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984
pubmed: 10229432
Coates LC, Baraliakos X, Blanco FJ et al (2021) The phenotype of axial spondyloarthritis: is it dependent on HLA-B27 status? Arthritis Care Res (Hoboken) 73:856–860. https://doi.org/10.1002/acr.24174
doi: 10.1002/acr.24174
pubmed: 32100954
Bennett AN, McGonagle D, O’Connor P, Hensor EM, Sivera F, Coates LC, Emery P, Marzo-Ortega H (2008) Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58:3413–3418. https://doi.org/10.1002/art.24024
doi: 10.1002/art.24024
pubmed: 18975311
Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewé R, Maksymowych W, van der Heijde D (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1–44. https://doi.org/10.1136/ard.2008.104018
doi: 10.1136/ard.2008.104018
Mandl P, Navarro-Compán V, Terslev L et al (2015) EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 74:1327–1339. https://doi.org/10.1136/annrheumdis-2014-206971
doi: 10.1136/annrheumdis-2014-206971
pubmed: 25837448
Poddubnyy D, Brandt H, Vahldiek J, Spiller I, Song IH, Rudwaleit M, Sieper J (2012) The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic. Ann Rheum Dis 71:1998–2001. https://doi.org/10.1136/annrheumdis-2012-201945
doi: 10.1136/annrheumdis-2012-201945
pubmed: 22915622
Diekhoff T, Hermann KG, Greese J, Schwenke C, Poddubnyy D, Hamm B, Sieper J (2017) Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study. Ann Rheum Dis 76:1502–1508. https://doi.org/10.1136/annrheumdis-2016-210640
doi: 10.1136/annrheumdis-2016-210640
pubmed: 28283515
Stal R, van Gaalen F, Sepriano A, Braun J, Reijnierse M, van den Berg R, van der Heijde D, Baraliakos X (2020) Facet joint ankylosis in r-axSpA: detection and 2-year progression on whole spine low-dose CT and comparison with syndesmophyte progression. Rheumatology (Oxford) 59:3776–3783. https://doi.org/10.1093/rheumatology/keaa155
doi: 10.1093/rheumatology/keaa155
pubmed: 32417911
Diekhoff T, Eshed I, Radny F, Ziegeler K, Proft F, Greese J, Deppe D, Biesen R, Hermann KG, Poddubnyy D (2022) Choose wisely: imaging for diagnosis of axial spondyloarthritis. Ann Rheum Dis 81:237–242. https://doi.org/10.1136/annrheumdis-2021-220136
doi: 10.1136/annrheumdis-2021-220136
pubmed: 34049855
Lee YJ, Lee SH, Ahn SM, Hong S, Oh JS, Lee CK, Yoo B, Kim YG (2023) When MRI would be useful in patients without evidence of sacroiliitis on radiographs? Rheumatol Int. https://doi.org/10.1007/s00296-023-05468-2
doi: 10.1007/s00296-023-05468-2
pubmed: 37733041
Ez-Zaitouni Z, Bakker PA, van Lunteren M et al (2017) The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: results from the SPACE and DESIR cohorts. Ann Rheum Dis 76:1731–1736. https://doi.org/10.1136/annrheumdis-2017-211486
doi: 10.1136/annrheumdis-2017-211486
pubmed: 28663306
Lukas C, Cyteval C, Dougados M, Weber U (2018) MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations “Not everything that glisters is gold (standard).” RMD Open 4:e000586. https://doi.org/10.1136/rmdopen-2017-000586
doi: 10.1136/rmdopen-2017-000586
pubmed: 29479474
pmcid: 5822619
Almodóvar R, Bueno Á, Batlle E et al (2019) Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice. Rheumatol Int 39:2119–2127. https://doi.org/10.1007/s00296-019-04441-2
doi: 10.1007/s00296-019-04441-2
pubmed: 31535169
de Winter J, de Hooge M, van de Sande M et al (2018) Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain. Arthritis Rheumatol 70:1042–1048. https://doi.org/10.1002/art.40475
doi: 10.1002/art.40475
pubmed: 29513924
pmcid: 6032910
Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783. https://doi.org/10.1136/ard.2009.108233
doi: 10.1136/ard.2009.108233
pubmed: 19297344
Lambert RG, Bakker PA, van der Heijde D et al (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 75:1958–1963. https://doi.org/10.1136/annrheumdis-2015-208642
doi: 10.1136/annrheumdis-2015-208642
pubmed: 26768408
Aggarwal R, Ringold S, Khanna D et al (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 67:891–897. https://doi.org/10.1002/acr.22583
doi: 10.1002/acr.22583
pubmed: 25776731
Landewé RB, van der Heijde DM (2017) Why CAPS criteria are not diagnostic criteria? Ann Rheum Dis 76:e7. https://doi.org/10.1136/annrheumdis-2016-210656
doi: 10.1136/annrheumdis-2016-210656
pubmed: 27799158
Dubreuil M, Deodhar AA (2017) Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol 29:317–322. https://doi.org/10.1097/BOR.0000000000000402
doi: 10.1097/BOR.0000000000000402
pubmed: 28376062
pmcid: 5810943
Landewé R, van Tubergen A (2015) Clinical Tools to Assess and Monitor Spondyloarthritis. Curr Rheumatol Rep 17:47. https://doi.org/10.1007/s11926-015-0522-3
doi: 10.1007/s11926-015-0522-3
pubmed: 26063534
pmcid: 4464370
Reveille JD (2015) Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol 34:1009–1018. https://doi.org/10.1007/s10067-015-2949-3
doi: 10.1007/s10067-015-2949-3
pubmed: 25939520
pmcid: 4488904
Michielsens C, Bolhuis TE, van Gaalen FA, van den Hoogen F, Verhoef LM, den Broeder N, den Broeder AA (2024) Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study. Scand J Rheumatol 53:180–187. https://doi.org/10.1080/03009742.2023.2213509
doi: 10.1080/03009742.2023.2213509
pubmed: 37339375
van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R; Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818. https://doi.org/10.1136/ard.2008.100826
doi: 10.1136/ard.2008.100826
Sundaram TG, Muhammed H, Aggarwal A, Gupta L (2020) A prospective study of novel disease activity indices for ankylosing spondylitis. Rheumatol Int 40:1843–1849. https://doi.org/10.1007/s00296-020-04662-w
doi: 10.1007/s00296-020-04662-w
pubmed: 32757024
Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D; Assessment of SpondyloArthritis international Society (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47–53. https://doi.org/10.1136/ard.2010.138594
doi: 10.1136/ard.2010.138594
Molto A, Gossec L, Meghnathi B, Landewé RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M, ASAS-FLARE study group, (2018) An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis 77:124–127. https://doi.org/10.1136/annrheumdis-2017-212178
doi: 10.1136/annrheumdis-2017-212178
pubmed: 29038299
Navarro-Compán V, Ramiro S, Deodhar A, Mease PJ, Rudwaleit M, de la Loge C, Fleurinck C, Taieb V, Mørup MF, Massow U, Kay J, Magrey M (2024) Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. RMD Open 10:e004040. https://doi.org/10.1136/rmdopen-2023-004040
doi: 10.1136/rmdopen-2023-004040
pubmed: 38599650
pmcid: 11015249
Brandt J, Listing J, Sieper J, Rudwaleit M, van der Heijde D, Braun J (2004) Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis. Ann Rheum Dis 63:1438–1444. https://doi.org/10.1136/ard.2003.016717
doi: 10.1136/ard.2003.016717
pubmed: 15044211
pmcid: 1754796
Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D; ASAS Working Group (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65:316–320. https://doi.org/10.1136/ard.2005.040758
doi: 10.1136/ard.2005.040758
Hallström M, Klingberg E, Deminger A, Rehnman JB, Geijer M, Forsblad-d’Elia H (2023) Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index. Arthritis Res Ther 25:182. https://doi.org/10.1186/s13075-023-03173-w
doi: 10.1186/s13075-023-03173-w
pubmed: 37749599
pmcid: 10521572
Carvalho PD, Ruyssen-Witrand A, Fonseca J, Marreiros A, Machado PM (2020) Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohort. RMD Open 6:e001356. https://doi.org/10.1136/rmdopen-2020-001356
doi: 10.1136/rmdopen-2020-001356
pubmed: 33060191
pmcid: 7642523
Biallas RL, Dean LE, Davidson L, Hollick R, Pathan E, Robertson L, Jones GT, Macfarlane GJ, Rotariu O (2022) Role of metrology in axial spondyloarthritis: does it provide unique information in assessing patients and predicting outcome? results from the British society for rheumatology biologic register for ankylosing spondylitis. Arthritis Care Res (Hoboken) 74:665–674. https://doi.org/10.1002/acr.24500
doi: 10.1002/acr.24500
pubmed: 33140891
Castro MP, Stebbings SM, Milosavljevic S, Bussey MD (2016) Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis. Clin Rheumatol 35:1777–1787. https://doi.org/10.1007/s10067-015-3056-1
doi: 10.1007/s10067-015-3056-1
pubmed: 26337175
Kiltz U, van der Heijde D, Boonen A et al (2015) Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 74:830–835. https://doi.org/10.1136/annrheumdis-2013-203967
doi: 10.1136/annrheumdis-2013-203967
pubmed: 24399232
Di Carlo M, Lato V, Di Matteo A, Carotti M, Salaffi F (2017) Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health Index. Rheumatol Int 37:713–718. https://doi.org/10.1007/s00296-016-3642-9
doi: 10.1007/s00296-016-3642-9
pubmed: 28063070
Akgul O, Bodur H, Ataman S, Yurdakul FG et al (2020) Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry. Rheumatol Int 40:1793–1801. https://doi.org/10.1007/s00296-020-04680-8
doi: 10.1007/s00296-020-04680-8
pubmed: 32814986
Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197–202. https://doi.org/10.1136/ard.46.3.197
doi: 10.1136/ard.46.3.197
pubmed: 3107483
pmcid: 1002099
Braun J, Brandt J, Listing J et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359:1187–1193. https://doi.org/10.1016/s0140-6736(02)08215-6
doi: 10.1016/s0140-6736(02)08215-6
pubmed: 11955536
Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, Sampalis J, Conner-Spady B (2009) Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 68:948–953. https://doi.org/10.1136/ard.2007.084244
doi: 10.1136/ard.2007.084244
pubmed: 18524792
Healy PJ, Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59:686–691. https://doi.org/10.1002/art.23568
doi: 10.1002/art.23568
pubmed: 18438903
Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van ver Tempel H, Mielants H, Dougados M, van der Heijde D, (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62:127–132. https://doi.org/10.1136/ard.62.2.127
doi: 10.1136/ard.62.2.127
pubmed: 12525381
pmcid: 1754445
Lukas C, Braun J, van der Heijde D, Hermann KG et al (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 34:862–870
pubmed: 17407241
Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, Conner-Spady B, Palsat J, Lambert RG (2005) Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53:703–709. https://doi.org/10.1002/art.21445
doi: 10.1002/art.21445
pubmed: 16208659
Creemers MC, Franssen MJ, Vant Hof MA, Gribnau FW, Van de Putte LB, van Riel PL (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64:127–129. https://doi.org/10.1136/ard.2004.020503
doi: 10.1136/ard.2004.020503
pubmed: 15051621
Cengiz M, Ataman Ş, Sunar İ, Yalçın AP, Yılmaz G, Elhan AH (2022) Evaluation of the early cervical structural change in patients with non-radiographic axial spondyloarthropathy. Rheumatol Int 42:495–502. https://doi.org/10.1007/s00296-021-04807-5
doi: 10.1007/s00296-021-04807-5
pubmed: 33675418
Ramiro S, Nikiphorou E, Sepriano A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82:19–34. https://doi.org/10.1136/ard-2022-223296
doi: 10.1136/ard-2022-223296
pubmed: 36270658
Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, Ramiro S, van der Heijde D, Nikiphorou E (2023) Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis 82:142–152. https://doi.org/10.1136/ard-2022-223297
doi: 10.1136/ard-2022-223297
pubmed: 36261247
Hirano F, van der Heijde D, van Gaalen FA, Landewé RBM, Gaujoux-Viala C, Ramiro S (2021) Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort. Rheumatology (Oxford) 60:316–321. https://doi.org/10.1093/rheumatology/keaa353
doi: 10.1093/rheumatology/keaa353
pubmed: 32766697
Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, Landewé R (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 73:1455–1461. https://doi.org/10.1136/annrheumdis-2014-205178
doi: 10.1136/annrheumdis-2014-205178
pubmed: 24812292
Landewé R, Dougados M, Mielants H, van der Tempel H, van der Heijde D (2009) Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 68:863–867. https://doi.org/10.1136/ard.2008.091793
doi: 10.1136/ard.2008.091793
pubmed: 18628283
Rausch Osthoff AK, Niedermann K, Braun J et al (2018) 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:1251–1260. https://doi.org/10.1136/annrheumdis-2018-213585
doi: 10.1136/annrheumdis-2018-213585
pubmed: 29997112
Zangi HA, Ndosi M, Adams J et al (2015) EULAR recommendations for patient education for people with inflammatory arthritis. Ann Rheum Dis 74:954–962. https://doi.org/10.1136/annrheumdis-2014-206807
doi: 10.1136/annrheumdis-2014-206807
pubmed: 25735643
Ansell RC, Shuto T, Busquets-Perez N, Hensor EM, Marzo-Ortega H, McGonagle D (2015) The role of biomechanical factors in ankylosing spondylitis: the patient’s perspective. Reumatismo 67:91–96. https://doi.org/10.4081/reumatismo.2015.853
doi: 10.4081/reumatismo.2015.853
pubmed: 26876187
Tan S, Dasgupta A, Yao J, Flynn JA, Yao L, Ward MM (2016) Spatial distribution of syndesmophytes along the vertebral rim in ankylosing spondylitis: preferential involvement of the posterolateral rim. Ann Rheum Dis 75:1951–1957. https://doi.org/10.1136/annrheumdis-2015-208802
doi: 10.1136/annrheumdis-2015-208802
pubmed: 26797721
Gwinnutt JM, Wieczorek M, Balanescu A et al (2023) 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis 82:48–56. https://doi.org/10.1136/annrheumdis-2021-222020
doi: 10.1136/annrheumdis-2021-222020
pubmed: 35260387
Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64:1388–1398. https://doi.org/10.1002/art.33465
doi: 10.1002/art.33465
pubmed: 22127957
Ramiro S, Landewé R, van Tubergen A, Boonen A, Stolwijk C, Dougados M, van den Bosch F, van der Heijde D (2015) Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open 1:e000153. https://doi.org/10.1136/rmdopen-2015-000153
doi: 10.1136/rmdopen-2015-000153
pubmed: 26535153
pmcid: 4623363
Baraliakos X, Kiltz U, Peters S et al (2017) Efficiency of treatment with nonsteroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis. Rheumatology (Oxford) 56:95–102. https://doi.org/10.1093/rheumatology/kew367
doi: 10.1093/rheumatology/kew367
pubmed: 27997346
Wanders A, Dv H, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M (2005) Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52:1756–1765. https://doi.org/10.1002/art.21054
doi: 10.1002/art.21054
pubmed: 15934081
Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M (2016) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 75:1438–1443. https://doi.org/10.1136/annrheumdis-2015-207897
doi: 10.1136/annrheumdis-2015-207897
pubmed: 26242443
Proft F, Muche B, Listing J, Rios-Rodriguez V, Sieper J, Poddubnyy D (2017) Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of structural damage in the spine over two years in patients with ankylosing spondylitis (CONSUL)—an open-label randomized controlled multicenter trial. BMJ Open 7:e014591. https://doi.org/10.1136/bmjopen-2016-014591
doi: 10.1136/bmjopen-2016-014591
pubmed: 28601821
pmcid: 5623356
Regel A, Sepriano A, Baraliakos X, van der Heijde D, Braun J, Landewé R, Van den Bosch F, Falzon L, Ramiro S (2017) Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3:e000397. https://doi.org/10.1136/rmdopen-2016-000397
doi: 10.1136/rmdopen-2016-000397
pubmed: 28176966
pmcid: 5278330
Harrison SR, Marzo-Ortega H (2023) Have therapeutics enhanced our knowledge of axial spondyloarthritis? Curr Rheumatol Rep 25:56–67. https://doi.org/10.1007/s11926-023-01097-7
doi: 10.1007/s11926-023-01097-7
pubmed: 36652160
pmcid: 9958165
Shentu H, Sha S, He Y, He M, Dong N, Huang Z, Lai H, Chen M, Huang J, Huang X (2024) Efficacy of TNF-α inhibitors in the treatment of nr-axSpA: a systematic review and meta-analysis based on randomized controlled trials. Int Arch Allergy Immunol 1:1–10. https://doi.org/10.1159/000536601
doi: 10.1159/000536601
Ørnbjerg LM, Brahe CH, Askling J et al (2019) Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Ann Rheum Dis 78:1536–1544. https://doi.org/10.1136/annrheumdis-2019-215427
doi: 10.1136/annrheumdis-2019-215427
pubmed: 31431486
Barkham N, Keen HI, Coates LC, O’Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60:946–954. https://doi.org/10.1002/art.24408
doi: 10.1002/art.24408
pubmed: 19333933
Garcia-Montoya L, Emery P (2021) Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials. Expert Opin Investig Drugs 30:1109–1124. https://doi.org/10.1080/13543784.2021.2010187
doi: 10.1080/13543784.2021.2010187
pubmed: 34842481
Yin Y, Wang M, Liu M, Zhou E, Ren T, Chang X, He M, Zeng K, Guo Y, Wu J (2020) Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Res Ther 22:111. https://doi.org/10.1186/s13075-020-02208-w
doi: 10.1186/s13075-020-02208-w
pubmed: 32398096
pmcid: 7216398
Deodhar A, Poddubnyy D, Pacheco-Tena C et al (2019) Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen-week results from a phase III randomized, double-blind, placebo-controlled trial in patients with prior inadequate response to or intolerance of tumor necrosis factor inhibitors. Arthritis Rheumatol 71:599–611. https://doi.org/10.1002/art.40753
doi: 10.1002/art.40753
pubmed: 30343531
pmcid: 6593790
Deodhar A, Sliwinska-Stanczyk P, Xu H et al (2021) Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 80:1004–1013. https://doi.org/10.1136/annrheumdis-2020-219601
doi: 10.1136/annrheumdis-2020-219601
pubmed: 33906853
van der Heijde D, Song IH, Pangan AL (2019) Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial. Lancet 394:2108–2117. https://doi.org/10.1016/S0140-6736(19)32534-6
doi: 10.1016/S0140-6736(19)32534-6
pubmed: 31732180
Deodhar A, Van den Bosch F, Poddubnyy D et al (2022) Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 400:369–379. https://doi.org/10.1016/S0140-6736(22)01212-0
doi: 10.1016/S0140-6736(22)01212-0
pubmed: 35908570
Haibel H, Fendler C, Listing J, Callhoff J, Braun J, Sieper J (2014) Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial. Ann Rheum Dis 73:243–246. https://doi.org/10.1136/annrheumdis-2012-203055
doi: 10.1136/annrheumdis-2012-203055
pubmed: 23625982
Dhir V, Mishra D, Samanta J (2021) Glucocorticoids in spondyloarthritis-systematic review and real-world analysis. Rheumatology (Oxford) 60:4463–4475. https://doi.org/10.1093/rheumatology/keab275
doi: 10.1093/rheumatology/keab275
pubmed: 33748829
Ma KS, Lee YH, Lin CJ, Shih PC, Wei JC (2023) Management of extra-articular manifestations in spondyloarthritis. Int J Rheum Dis 26:183–186. https://doi.org/10.1111/1756-185X.14485
doi: 10.1111/1756-185X.14485
pubmed: 36703270
Evangelatos G, Bamias G, Kitas GD, Kollias G, Sfikakis PP (2022) The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era. Rheumatol Int 42:1493–1511. https://doi.org/10.1007/s00296-022-05136-x
doi: 10.1007/s00296-022-05136-x
pubmed: 35503130
pmcid: 9063259
Lindström U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d’Elia H, Jacobsson LTH, Askling J (2021) Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Ann Rheum Dis 80:1445–1452. https://doi.org/10.1136/annrheumdis-2021-220420
doi: 10.1136/annrheumdis-2021-220420
pubmed: 34130984
Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T (2019) Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Ann Rheum Dis 78:473–479. https://doi.org/10.1136/annrheumdis-2018-214273
doi: 10.1136/annrheumdis-2018-214273
pubmed: 30674475
Mease PJ, Smolen JS, Behrens F et al (2020) A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Ann Rheum Dis 79:123–131. https://doi.org/10.1136/annrheumdis-2019-215386
doi: 10.1136/annrheumdis-2019-215386
pubmed: 31563894
McInnes IB, Behrens F, Mease PJ et al (2020) Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial. Lancet 395:1496–1505. https://doi.org/10.1016/S0140-6736(20)30564-X
doi: 10.1016/S0140-6736(20)30564-X
pubmed: 32386593
Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A (2015) Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis 74:65–73. https://doi.org/10.1136/annrheumdis-2013-203582
doi: 10.1136/annrheumdis-2013-203582
pubmed: 23999006
Kjeken I, Bø I, Rønningen A, Spada C, Mowinckel P, Hagen KB, Dagfinrud H (2013) A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial. J Rehabil Med 45:260–267. https://doi.org/10.2340/16501977-1078
doi: 10.2340/16501977-1078
pubmed: 23138412
Rademacher J, Müllner H, Diekhoff T, Haibel H, Igel S, Pohlmann D, Proft F, Protopopov M, Rios Rodriguez V, Torgutalp M, Pleyer U, Poddubnyy D (2023) Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol 75:210–219. https://doi.org/10.1002/art.42315
doi: 10.1002/art.42315
pubmed: 35905288
Aghdam MRF, Vodovnik A, Hameed RA (2019) Role of telemedicine in multidisciplinary team meetings. J Pathol Inform 10:35. https://doi.org/10.4103/jpi.jpi_20_19
doi: 10.4103/jpi.jpi_20_19
pubmed: 31799021
pmcid: 6883478
Das P, Haldar R, Santhanam S (2021) Therapeutic exercises and rehabilitation in axial spondyloarthropathy: Balancing benefits with unique challenges in the Asia-Pacific countries. Int J Rheum Dis 24(2):170–182. https://doi.org/10.1111/1756-185X.14035
doi: 10.1111/1756-185X.14035
pubmed: 33244895
Klemm P, Preusler P, Hudowenz O, Asendorf T, Müller-Ladner U, Neumann E, Lange U, Tarner IH (2021) Multimodal rheumatologic complex treatment in patients with spondyloarthritis - a prospective study. Eur J Intern Med 93:42–49. https://doi.org/10.1016/j.ejim.2021.07.005
doi: 10.1016/j.ejim.2021.07.005
pubmed: 34344550
Gudu T, Jadon DR (2020) Multidisciplinary working in the management of axial and peripheral spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720X20975888
doi: 10.1177/1759720X20975888
pubmed: 33354231
pmcid: 7734487
Garrido-Cumbrera M, Bundy C, Navarro-Compán V, Makri S, Sanz-Gómez S, Christen L, Mahapatra R, Delgado-Domínguez CJ, Poddubnyy D (2021) Patient-reported impact of axial spondyloarthritis on working life: results from the european map of axial spondyloarthritis survey. Arthritis Care Res (Hoboken) 73:1826–1833. https://doi.org/10.1002/acr.24426
doi: 10.1002/acr.24426
pubmed: 32813333
Wilson N, Liu J, Adamjee Q, Di Giorgio S, Steer S, Hutton J, Lempp H (2023) Exploring the emotional impact of axial Spondyloarthritis: a systematic review and thematic synthesis of qualitative studies and a review of social media. BMC Rheumatol 7:26. https://doi.org/10.1186/s41927-023-00351-w
doi: 10.1186/s41927-023-00351-w
pubmed: 37608395
pmcid: 10464274
So H, Tam LS (2021) Cardiovascular disease and depression in psoriatic arthritis: Multidimensional comorbidities requiring multidisciplinary management. Best Pract Res Clin Rheumatol 35:101689. https://doi.org/10.1016/j.berh.2021.101689
doi: 10.1016/j.berh.2021.101689
pubmed: 33965339
Ahmed S, Grainger R, Santosa A et al (2022) APLAR recommendations on the practice of telemedicine in rheumatology. Int J Rheum Dis 25:247–258. https://doi.org/10.1111/1756-185X.14286
doi: 10.1111/1756-185X.14286
pubmed: 35043576
Mago A, Aggarwal V, Gupta L (2021) Telerheumatology and its interplay with patient-initiated care. Rheumatol Int 41:1883–1884. https://doi.org/10.1007/s00296-021-04930-3
doi: 10.1007/s00296-021-04930-3
pubmed: 34165605
pmcid: 8223232
de Thurah A, Bosch P, Marques A et al (2022) 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Ann Rheum Dis 81:1065–1071. https://doi.org/10.1136/annrheumdis-2022-222341
doi: 10.1136/annrheumdis-2022-222341
pubmed: 35470160
Hannah L, von Sophie R, Gabriella RM et al (2024) Stepwise asynchronous telehealth assessment of patients with suspected axial spondyloarthritis: results from a pilot study. Rheumatol Int 44:173–180. https://doi.org/10.1007/s00296-023-05360-z
doi: 10.1007/s00296-023-05360-z
pubmed: 37316631
von Rohr S, Knitza J, Grahammer M, Schmalzing M, Kuhn S, Schett G, Ramming A, Labinsky H (2023) Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study. Rheumatol Int 43:1905–1911. https://doi.org/10.1007/s00296-023-05392-5
doi: 10.1007/s00296-023-05392-5
Kempin R, Richter JG, Schlegel A, Baraliakos X, Tsiami S, Buehring B, Kiefer D, Braun J, Kiltz U (2022) Monitoring of disease activity with a smartphone app in routine clinical care in patients with axial spondyloarthritis. J Rheumatol 49:878–884. https://doi.org/10.3899/jrheum.211116
doi: 10.3899/jrheum.211116
pubmed: 35428719
Marques A, Bosch P, de Thurah A et al (2022) Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases. RMD Open 8:e002290. https://doi.org/10.1136/rmdopen-2022-002290
doi: 10.1136/rmdopen-2022-002290
pubmed: 35523520
pmcid: 9083395
Paul L, McDonald MT, McConnachie A, Siebert S, Coulter EH (2024) Online physiotherapy for people with axial spondyloarthritis: quantitative and qualitative data from a cohort study. Rheumatol Int 44:145–156. https://doi.org/10.1007/s00296-023-05456-6
doi: 10.1007/s00296-023-05456-6
pubmed: 37733042